Top Performing Unleveraged ETFs Last Week
These were last week’s top performing ETFs. We’ve excluded funds which use leverage or make inverse bets on their underlying assets.
Last week’s top performers table was dominated by biotech and healthcare funds. In fact, only two funds on the list weren’t from that sector: the MLCX Biofuels ETN (FUE C) and the United States Gasoline Fund (UGA A). FUE has had a strong month with 18.3% returns, but little investor interest. UGA on the other hand has seen weak returns for the past month and steady outflows despite this week’s performance.
For our biotech funds, the SPDR S&P Biotech ETF’s (XBI B-) returns of 11.3% were accompanied by strong inflows for the week as well. The fund saw $703 million in new assets over the past week, accounting for almost 11% of XBI’s total assets.
1 Week Return
Defiance Nasdaq Junior Biotechnology ETF
Principal Healthcare Innovators Index ETF
MLCX Biofuels ETN
Invesco DWA Healthcare Momentum ETF
Virtus LifeSci Biotech Clinical Trials ETF
iShares Genomics Immunology and Healthcare ETF
SPDR S&P Biotech ETF
Loncar Cancer Immunotherapy ETF
United States Gasoline Fund
ALPS Medical Breakthroughs ETF